PCD PC 2011-09-21 Webex: Difference between revisions
Jump to navigation
Jump to search
m →Discussion: continue entries |
m →Discussion: begin entering discussion |
||
| Line 88: | Line 88: | ||
The slide presentation by Valentina Ferrarini is at | The slide presentation by Valentina Ferrarini is at | ||
: ftp://iheyr2@ftp.ihe.net/Patient_Care_Devices/IHEPCDyr7-2012-2013/Cycle_7_Proposals/XTHW-WD_profile_proposal_presentation.ppt | : ftp://iheyr2@ftp.ihe.net/Patient_Care_Devices/IHEPCDyr7-2012-2013/Cycle_7_Proposals/XTHW-WD_profile_proposal_presentation.ppt | ||
* Valentina Ferrarini (Arsenal.IT) presented the __ proposal. The slides for this presentation are available at __ . Todd asked if they considered using CDA and Valentina indicated they had. Ken asked what work is required within PCD. Valentina responded XDW profile is required for the workflow. | |||
* Axel Wirth (Symantec) presented the Device Cybersecurity proposal named CE/IT Integration and Management of Medical Devices. He noted that the issues are not limited to PCD equipment types, but includes imaging and other modalities. | |||
* Todd Cooper (Breakthrough Solutions) presented the Device Specialization – General Content Profile proposal. It focuses on MEM. John Garguilo asked about the relationship of RTM to volume 3: Todd responded that volume 3 will address the design of RTM and refer to the RTM table located elsewhere. Content of volumes 2, 3 will be discussed at the F2F. | |||
* Todd Cooper presented Device Specialization – Infusion Pump Content. He noted that the Pharmacy domain, AAMI and ACCE will be interested in this effort. PCPI was suggested as another interested group that includes representatives from other societies. F2F discussion will need to address a number of issues, such as whether syringe pumps are a separate profile, how to address infusion therapy. Paul and Donald Gregg noted regulatory differences between Europe and FDA regulation (PK, PD, PI and therapies). Paul expressed a desire to be inclusive. | |||
* Todd Cooper described the WP and summarized the discussion with the Pharmacy domain that addresses the larger picture. Two diagrams describe each of the two domains’ efforts. Erin is developing a single diagram in an attempt to move forward. The IHE and HL7 Pharmacy groups meet the first week in October and will address the proposed WP. | |||
Revision as of 22:15, 26 September 2011
Patient Care Device Domain
Meeting Purpose
PC Regularly Scheduled Meeting
WebEx Information
Topic: PCD Planning Committee
- Regularly Scheduled Meeting Time
Date: Wednesday, September 21, 2011
Time: 11:00 am, Eastern Time (New York)
Duration: 60 Minutes
Proposed Agenda
- 1. Agenda Approval
- 2. Review Discussion Summaries: Planning Committee September 7PCD PC 2011-09-07 Webex
- 3. Brief Workitem Proposals http://wiki.ihe.net/index.php?title=PCD_Proposals_Cycle_7
- - Cross Enterprise TeleHomeMonitoring Workflow Definition (XTHM-WD)- Valentina Ferrarini (Consorzio Arsenàl.IT)
- - Device Cybersecurity - Axel (Symantec)
- - Device Specializations - General Content Profile - Todd (Breakthrough Solutions)
- - Device Specialization - Infusion Pump - Todd (Breakthrough Solutions)
- - Medication Administration Clinical Integration White Paper - Todd (Breakthrough Solutions)
- The remaining proposals will be addressed next week. Next week's meeting will be a PCD meeting.
- PC members will be asked to vote on the proposals to determine which ones go to the next step.
- 4. F2F Update: Oct. 18-21, Kansas City; registration; http://wiki.ihe.net/index.php?title=PCD_PC%26TC_2011-10-18_to_21_F2F
- 5. Supplement Status Updates - Deferred
- ADQ
- Event Comm
- WCM
- 6. Connectathon
- 7. HIMSS12
- 8. Action Item Review - Deferred
- 9. Next and Recent Meetings - Changes described below
- 10. Additional Business
Action Items from Previous Meetings
See PCD Planning Committee Action Items.
Significant changes, other than dates, will be in bold.
Participants
Placeholder
- Chair: ____
- ______
Discussion
Discussion Summaries do not require formal approval, while minutes of meetings where votes are taken do. Participants are encouraged to review and bring up significant issues with discussion summaries of previous meetings. Votes will be taken to approve meetings where votes took place; these may be email ballots.
Item Topic Discussion 1 Introductions & Agenda Review
- ChairStatus/Discussion: Decisions/Issues:
- Agenda approved and discussion of items other than review of the previous meeting's summary and discussion of Brief Profile Proposals was limited.
Action(s):
2 Discussion Summary or Approval of Minutes
- ChairStatus/Discussion: - Discussion Summary of previous meeting was accepted
Decisions/Issues:
Action(s):
3 Agenda Items
- As NotedStatus/Discussion: This meeting was recorded, although the recording started a few minutes late. It is available at
- https://himss.webex.com/himss/lsr.php?AT=pb&SP=MC&rID=54079182&rKey=ad1b6dc06426efce
- titled as: PCD Planning and Technical Committees Wednesdays-20110921 1517-1, Wednesday, September 21, 2011 11:17 am New York Time, 53 Minutes
The slide presentation by Valentina Ferrarini is at- Valentina Ferrarini (Arsenal.IT) presented the __ proposal. The slides for this presentation are available at __ . Todd asked if they considered using CDA and Valentina indicated they had. Ken asked what work is required within PCD. Valentina responded XDW profile is required for the workflow.
- Axel Wirth (Symantec) presented the Device Cybersecurity proposal named CE/IT Integration and Management of Medical Devices. He noted that the issues are not limited to PCD equipment types, but includes imaging and other modalities.
- Todd Cooper (Breakthrough Solutions) presented the Device Specialization – General Content Profile proposal. It focuses on MEM. John Garguilo asked about the relationship of RTM to volume 3: Todd responded that volume 3 will address the design of RTM and refer to the RTM table located elsewhere. Content of volumes 2, 3 will be discussed at the F2F.
- Todd Cooper presented Device Specialization – Infusion Pump Content. He noted that the Pharmacy domain, AAMI and ACCE will be interested in this effort. PCPI was suggested as another interested group that includes representatives from other societies. F2F discussion will need to address a number of issues, such as whether syringe pumps are a separate profile, how to address infusion therapy. Paul and Donald Gregg noted regulatory differences between Europe and FDA regulation (PK, PD, PI and therapies). Paul expressed a desire to be inclusive.
- Todd Cooper described the WP and summarized the discussion with the Pharmacy domain that addresses the larger picture. Two diagrams describe each of the two domains’ efforts. Erin is developing a single diagram in an attempt to move forward. The IHE and HL7 Pharmacy groups meet the first week in October and will address the proposed WP.
Decisions/Issues:Action(s):
4 xx
- As NotedStatus/Discussion:
Decisions/Issues:Action(s):
Next Meetings
The next meetings are:
The next meetings are:
PC September 28, 2011 PCD PC 2011-09-28 Webex
Type of meeting on October 5 meeting TBD
Joint PC and TC October 12, 2011 PCD PC&TC 2011-10-12 Webex
F2F in Kansas City Oct. 18 - 21
Meetings following the F2F TBD